News & Media
Abionic Webinar – Guiding Clinical Care Using Pancreatic Stone Protein
Another successful webinar was held by Abionic SA on September 22nd, 2022. More than 240 attendees from all over the world had the opportunity to connect and tune into this educational session where it was highlighted the role of Point-Of-Care (POC) testing in the early identification and management of sepsis and moreover, how the use of Pancreatic Stone Protein (PSP) can guide clinical care.
Prime Biosciences signs distribution agreement with Calmark Sweden AB
Prime Biosciences PC announces that has entered into an exclusive distribution agreement with Calmark Sweden AB (publ) for their innovative Neo Platform.
Prime Biosciences participated in the Panhellenic Conference for the 90 years of the Hellenic Society for Microbiology
The Panhellenic Conference for the 90 years of the Hellenic Society for Microbiology was successfully completed, in which we gladly participated through a satellite symposium entitled "Pancreatic Stone Protein to improve the early identification of sepsis".
Abionic Webinar - Advancing the diagnosis of sepsis in the intensive care units
Real world evidence on the practical implementation of the Pancreatic Stone Protein (PSP) sepsis test was demonstrated at the webinar held by Abionic SA on September 22, 2021. The live discussion on sepsis, chaired by Professor Pedro Póvoa, joined renowned scientists, including Dr. Maria Petraki, MD, Director of ICU - HDU of Mediterraneo Hospital in Athens.
Implementation of a rapid diagnostic test in periprosthetic joint infection (Lyfstone® Calprotectin) in daily practice
The European Bone and Joint Infection Society (EBJIS) launched a new model of diagnosing Periprosthetic Joint Infection (PJI). The current approach from EBJIS with the different rule-in criteria and the need for a rule-out tool has been presented in a webinar.
New data confirms the clinical benefit of PSP for the diagnosis of severe infections in hospitalized adults
Critical Care, the top-ranked open access journal in the field of critical care medicine, published the results of a study led by Lausanne University Hospital’s Dr Philippe Eggimann and Bern University Hospital’s Dr Yok-Ai Que this month [1]. The authors analyzed pooled data from five cohorts showing that the Pancreatic stone protein (PSP) biomarker outperforms both C-reactive protein (CRP) and procalcitonin (PCT), two canonical markers of infection, to diagnose severe infection in hospitalized patients.
